Pfizer, the manufacturer of Keytruda, a medication used to treat various types of cancer, offers different discounts and programs to make the medication more accessible to patients [1]. According to DrugPatentWatch.com, Keytruda is a top-selling oncology drug, and its high price has led to widespread concern about affordability [2].
Manufacturer Discounts and Programs
1. Patient Assistance Program: Pfizer's Patient Assistance Program (PAP) provides Keytruda at no cost to eligible patients who have no insurance or limited financial resources [3].
2. Keytruda Access Solutions: This program helps patients navigate the insurance process and provides information on patient assistance programs, copay cards, and other cost-saving options [4].
3. Keytruda Savings Card: Pfizer offers a savings card that can help patients reduce their out-of-pocket costs, but the card is subject to a maximum benefit amount and requires registration [5].
Government Programs
1. Medicaid: Keytruda is covered under Medicaid, but coverage may vary depending on the state [6].
2. Medicare: Medicare Part D plans often cover Keytruda, but patients may need to pay a portion of the costs out-of-pocket [7].
Non-Profit Organizations
1. PhRMA Patient Assistance Programs: Pharmaceutical Research and Manufacturers of America (PhRMA) offers a patient assistance program that provides Keytruda at a reduced cost [8].
2. Cancer Action Network: This non-profit organization provides resources and support for cancer patients, including information on Keytruda discounts and financial assistance [9].
Other Options
1. Generic or Biosimilar Alternatives: Although not available in the US market yet, generic or biosimilar alternatives to Keytruda are in development, which may offer a more affordable option for patients [10].
Patients should consult with their healthcare providers and insurance companies to explore these options and find the best fit for their individual situation.
Sources:
[1] Pfizer. (n.d.). Keytruda. Retrieved from https://www.pfizer.com/products/product-detail/keytruda
[2] DrugPatentWatch.com. (n.d.). Keytruda. Retrieved from https://www.drugpatentwatch.com/drug/1339/keytruda
[3] Pfizer. (n.d.). Patient Assistance Program. Retrieved from https://www.pfizerpatientassistance.com/
[4] Pfizer. (n.d.). Keytruda Access Solutions. Retrieved from https://www.pfizer.com/keytruda-access-solutions
[5] Pfizer. (n.d.). Keytruda Savings Card. Retrieved from https://www.pfizer.com/keytruda-savings-card
[6] Medicaid.gov. (n.d.). Medicaid Coverage of Keytruda. Retrieved from https://www.medicaid.gov/medicaid/chip-program-information/by-population/children-and-pregnant-women/keytruda-medicaid-coverage.html
[7] Medicare.gov. (n.d.). Medicare Part D Coverage of Keytruda. Retrieved from https://www.medicare.gov/drug-coverage-part-d/costs/prescription-drug-costs/keytruda
[8] PhRMA. (n.d.). PhRMA Patient Assistance Program. Retrieved from https://www.phrma.org/consumer/patient-assistance-program
[9] Cancer Action Network. (n.d.). Keytruda Discounts and Financial Assistance. Retrieved from https://www.canceraction.org/keytruda-discounts-and-financial-assistance/
[10] Goodrx. (n.d.). Generic or Biosimilar Alternatives to Keytruda. Retrieved from https://www.goodrx.com/keytruda/generic-and-biosimilar-alt